Cooper University Health Care First in the Region to Implant Next-Generation Watchman FLXTM Device
Cooper is one of approximately 40 sites in the United States and the only hospital in the Philadelphia region participating in a clinical trial for Boston Scientific’s Watchman FLXTM device. The Watchman FLX is the next generation of a potentially life-changing catheter-based (or non-surgically delivered) device designed to close the left atrial appendage in order to reduce the risk of stroke in certain patients with atrial fibrillation (AFib).… Read more.